Concepedia

CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors

Jasmin Dittmann, Karin Keller-Matschke, Toni Weinschenk, Thomas Kratt, Tobias Heck, H. Becker, Stefan Stevanović, Hans‐Georg Rammensee, Cécile Gouttefangeas

Cancer Immunology Immunotherapy · 2004 · 13 citations · 48 references

DOIFull text

Open access

Concepts

References

48

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.

Bryan Fisk, Tana Blevins, J. Taylor Wharton et al. · The Journal of Experimental Medicine · 1995 · 542 citations · Full text

, , +17

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells

Peter Brossart, Stefan Wirths, Gernot Stuhler et al. · Blood · 2000 · 540 citations

, , +14

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

Kwong-Yok Tsang, S Zaremba, Carol Nieroda et al. · JNCI Journal of the National Cancer Institute · 1995 · 498 citations

, , +17

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

George E. Peoples, Peter S. Goedegebuure, Robert W. Smith et al. · Proceedings of the National Academy of Sciences · 1995 · 440 citations

, , +17

Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide–Based Vaccines

Mary L. Disis, Theodore A. Gooley, Kristine Rinn et al. · Journal of Clinical Oncology · 2002 · 425 citations

, , +17